Pfizer and BioNTech companies have offered to supply 50 million doses of their COVID-19 vaccine to Africa for healthcare workers. The vaccine will be delivered in batches from March to the end of 2021.
Meanwhile, Pfizer had broken through the downtrend resistance line and then tested it. The price moves in an ascending channel and the most pleasant entry point is 36.6 if you know what I mean.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.